|Bid||22.84 x 900|
|Ask||22.84 x 800|
|Day's range||22.62 - 23.51|
|52-week range||19.93 - 43.55|
|Beta (3Y monthly)||1.19|
|PE ratio (TTM)||N/A|
|Earnings date||1 Nov 2019|
|Forward dividend & yield||N/A (N/A)|
|1y target est||24.33|
American Anesthesiology, a MEDNAX company and leading anesthesiology physician services provider, will exhibit at the ANESTHESIOLOGY® 2019 annual meeting presented by the American Society of Anesthesiologists from Oct.
MEDNAX, Inc. (MD), will host an investor conference call and webcast on Friday, November 1, 2019 at 9:00 a.m. ET, to discuss results from operations for the quarter and the nine months ended September 30, 2019. The investor conference call will be webcast and can be accessed at MEDNAX’s website, www.mednax.com/investors. MEDNAX, Inc. is a national health solutions partner comprised of the nation's leading providers of physician services.
MEDNAX, Inc. (MD) (“MEDNAX” or “the Company”) and Frazier Healthcare Partners (“Frazier”) today announced that they have entered into a definitive agreement under which MEDNAX will sell its MedData business to Frazier. MedData is a leading provider of technology-enabled management services for hospitals, health systems and healthcare providers. For four decades, MedData has been providing innovative solutions to the medical community and serving hundreds of millions of patients across numerous medical specialties.
MEDNAX, Inc. (MD), today announced its affiliation with CENTA, P.L., a private pediatric otolaryngology practice based in Orlando, Fla. Founded in 2006, CENTA is an established group that has provided pediatric otolaryngology, allergy and audiology services in Central Florida for more than 12 years. “With the support of the MEDNAX national network, we can better navigate the challenging healthcare environment and focus more on patient care and less on administrative functions,” said James Kosko, M.D., who will serve as medical director for the practice.
Mednax (MD) delivered earnings and revenue surprises of 2.30% and 0.07%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
Molina Healthcare's (MOH) second-quarter earnings are likely to be cushioned by its strategic divestitures as well as cost-reduction plans, partly offset by lower revenues.
Mednax (MD) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.